Beximco Pharmaceuticals Overview

  • Year Founded
  • 1976

Year Founded

  • Status
  • Public

  • Employees
  • 1,223

Employees

  • Stock Symbol
  • BXPHARMA

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.16
  • (As of Wednesday Closing)

Beximco Pharmaceuticals General Information

Description

Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 19 Dhanmondi R/A
  • Road Number 7
  • Dhaka, 1205
  • Bangladesh
+880
Primary Industry
Pharmaceuticals
Stock Exchange
DHA
Vertical(s)
Corporate Office
  • 19 Dhanmondi R/A
  • Road Number 7
  • Dhaka, 1205
  • Bangladesh
+880

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beximco Pharmaceuticals Stock Performance

As of 18-Nov-2026, Beximco Pharmaceuticals’s stock price is $1.16. Its current market cap is $517M with 446M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.16 $1.17 $0.80 - $1.27 $517M 446M 570K $0.16

Beximco Pharmaceuticals Financials Summary

As of 30-Jun-2026, Beximco Pharmaceuticals has a trailing 12-month revenue of $455M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 519,649 519,649 373,330 518,393
Revenue 454,547 454,547 402,827 394,808
EBITDA 102,131 102,131 97,636 94,492
Net Income 72,686 72,686 56,919 51,846
Total Assets 651,114 651,114 591,880 581,780
Total Debt 37,147 37,147 40,126 50,552
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Beximco Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beximco Pharmaceuticals‘s full profile, request access.

Request a free trial

Beximco Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation
Pharmaceuticals
Dhaka, Bangladesh
1,223 As of 2025

Ahmedabad, India
 

Dhaka, Bangladesh
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Beximco Pharmaceuticals Competitors (62)

One of Beximco Pharmaceuticals’s 62 competitors is Zydus Lifesciences, a Corporation company based in Ahmedabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zydus Lifesciences Corporation Ahmedabad, India
Popular Pharmaceuticals Private Debt Financed Dhaka, Bangladesh
Medis ( Pharmaceuticals) Corporation Hafnarfjordur, Iceland
Amneal Pharmaceuticals Formerly PE-Backed Bridgewater, NJ
Bluefish Pharmaceuticals Private Equity-Backed Stockholm, Sweden
You’re viewing 5 of 62 competitors. Get the full list »

Beximco Pharmaceuticals Patents

Beximco Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015903141-A0 Controlled release formulations of paracetamol Inactive 05-Aug-2015
AU-2016210691-A1 Controlled release formulations of paracetamol Inactive 05-Aug-2015

Beximco Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beximco Pharmaceuticals Investments & Acquisitions (3)

Beximco Pharmaceuticals’s most recent deal was a Merger/Acquisition with Sanofi Bangladesh for . The deal was made on 10-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sanofi Bangladesh 10-Apr-2021 Merger/Acquisition Pharmaceuticals
Sandoz Pharmaceuticals (8 Abbreviated New Drug Applications) 20-Feb-2019 Corporate Asset Purchase Buildings and Property
Nuvista Pharma 02-Apr-2018 Merger/Acquisition Pharmaceuticals
To view Beximco Pharmaceuticals’s complete investments and acquisitions history, request access »

Beximco Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Beximco Pharmaceuticals’s complete esg history, request access »

Beximco Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Nuvista Pharma Dhaka, Bangladesh 1963

Beximco Pharmaceuticals FAQs

  • When was Beximco Pharmaceuticals founded?

    Beximco Pharmaceuticals was founded in 1976.

  • Where is Beximco Pharmaceuticals headquartered?

    Beximco Pharmaceuticals is headquartered in Dhaka, Bangladesh.

  • What is the size of Beximco Pharmaceuticals?

    Beximco Pharmaceuticals has 1,223 total employees.

  • What industry is Beximco Pharmaceuticals in?

    Beximco Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Beximco Pharmaceuticals a private or public company?

    Beximco Pharmaceuticals is a Public company.

  • What is Beximco Pharmaceuticals’s stock symbol?

    The ticker symbol for Beximco Pharmaceuticals is BXPHARMA.

  • What is the current stock price of Beximco Pharmaceuticals?

    As of 18-Nov-2026 the stock price of Beximco Pharmaceuticals is $1.16.

  • What is the current market cap of Beximco Pharmaceuticals?

    The current market capitalization of Beximco Pharmaceuticals is $517M.

  • What is Beximco Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Beximco Pharmaceuticals is $455M.

  • Who are Beximco Pharmaceuticals’s competitors?

    Zydus Lifesciences, Popular Pharmaceuticals, Medis ( Pharmaceuticals), Amneal Pharmaceuticals, and Bluefish Pharmaceuticals are some of the 62 competitors of Beximco Pharmaceuticals.

  • What is Beximco Pharmaceuticals’s annual earnings per share (EPS)?

    Beximco Pharmaceuticals’s EPS for 12 months was $0.16.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process